Immucell Q3 Sales Jump 46% On Strong Volume, Gross Margin 44.2%
Immucell Corp reported a 46.0% increase in product sales to $8.0 million and a $953,000 net income for Q3 2026, despite a post-2025 restocking adjustment.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed